These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 29590130)

  • 1. Private sector tuberculosis prevention in the US: Characteristics associated with interferon-gamma release assay or tuberculin skin testing.
    Stockbridge EL; Miller TL; Carlson EK; Ho C
    PLoS One; 2018; 13(3):e0193432. PubMed ID: 29590130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon gamma release assay tests are associated with persistence and completion of latent tuberculosis infection treatment in the United States: Evidence from commercial insurance data.
    Stockbridge EL; Loethen AD; Annan E; Miller TL
    PLoS One; 2020; 15(12):e0243102. PubMed ID: 33270737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of an interferon-gamma release assay to screen for pediatric latent tuberculosis infection in the eastern region of the Emirate of Abu Dhabi.
    Al Mekaini LA; Al Jabri ON; Narchi H; Kamal SM; Mabrook A; Al Kuwaiti MM; Sheek-Hussein MM; Souid AK; Alsuwaidi AR
    Int J Infect Dis; 2014 Jun; 23():4-7. PubMed ID: 24657274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a new interferon-gamma release assay and comparison to tuberculin skin test during a tuberculosis outbreak.
    Song Q; Guo H; Zhong H; Liu Z; Chen X; Wang C; Touzjian N; Lv Y; Lu X; Wang Q
    Int J Infect Dis; 2012 Jul; 16(7):e522-6. PubMed ID: 22542006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cross-sectional study of latent tuberculosis infection, insurance coverage, and usual sources of health care among non-US-born persons in the United States.
    Annan E; Stockbridge EL; Katz D; Mun EY; Miller TL
    Medicine (Baltimore); 2021 Feb; 100(7):e24838. PubMed ID: 33607853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing an Interferon Gamma Release Assay with the Tuberculin Skin Test During Pregnancy: Implications for Tuberculosis Screening During Prenatal Care.
    Molina R; Venkatesh K; Schantz-Dunn J; Meadows A; Nour N; Diouf K
    Matern Child Health J; 2016 Jun; 20(6):1314-20. PubMed ID: 26645617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for Mycobacterium tuberculosis using an interferon-gamma release assay.
    Simpson T; Fox J; Crouse K; Field K
    J Public Health Manag Pract; 2012; 18(4):E19-25. PubMed ID: 22635200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of latent tuberculosis infection in BCG-vaccinated healthcare workers by using an interferon-gamma release assay and the tuberculin skin test in an intermediate tuberculosis burden country.
    Hung WT; Lee SS; Sy CL; Wu KS; Chen JK; Tsai HC; Chen YS
    J Microbiol Immunol Infect; 2015 Apr; 48(2):147-52. PubMed ID: 24071516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of latent tuberculosis infection treatment completion in the US private sector: an analysis of administrative claims data.
    Stockbridge EL; Miller TL; Carlson EK; Ho C
    BMC Public Health; 2018 May; 18(1):662. PubMed ID: 29843664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for latent tuberculosis infection in patients with chronic inflammatory arthritis: discrepancies between tuberculin skin test and interferon-γ release assay results.
    Costantino F; de Carvalho Bittencourt M; Rat AC; Loeuille D; Dintinger H; Béné MC; Faure G; Chary-Valckenaere I
    J Rheumatol; 2013 Dec; 40(12):1986-93. PubMed ID: 24085550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tuberculosis screening in Portuguese healthcare workers using the tuberculin skin test and the interferon-gamma release assay.
    Torres Costa J; Sá R; Cardoso MJ; Silva R; Ferreira J; Ribeiro C; Miranda M; Plácido JL; Nienhaus A
    Eur Respir J; 2009 Dec; 34(6):1423-8. PubMed ID: 19948911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Supplemental use of an interferon-gamma release assay in a state-wide tuberculosis contact tracing program in Victoria: a six-year review.
    Goebel KM; Tay EL; Denholm JT
    Commun Dis Intell Q Rep; 2015 Jun; 39(2):E191-6. PubMed ID: 26234253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative performance of tuberculin skin test, QuantiFERON-TB-Gold In Tube assay, and T-Spot.TB test in contact investigations for tuberculosis.
    Diel R; Loddenkemper R; Meywald-Walter K; Gottschalk R; Nienhaus A
    Chest; 2009 Apr; 135(4):1010-1018. PubMed ID: 19017873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of a commercial interferon-gamma release assay and tuberculin skin test for the detection of latent tuberculosis infection in Hong Kong arthritis patients who are candidates for biologic agents.
    So H; Yuen CS; Yip RM
    Hong Kong Med J; 2017 Jun; 23(3):246-50. PubMed ID: 28126971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of TST and IGRA in Diagnosis of Latent Tuberculosis Infection in a High TB-Burden Setting.
    Sharma SK; Vashishtha R; Chauhan LS; Sreenivas V; Seth D
    PLoS One; 2017; 12(1):e0169539. PubMed ID: 28060926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of latent tuberculosis infection in persons with and without human immunodeficiency virus infection using two interferon-gamma release assays and tuberculin skin test in a low human immunodeficiency virus prevalence, intermediate tuberculosis-burden country.
    Lin WC; Lin HH; Lee SS; Sy CL; Wu KS; Chen JK; Tsai HC; Chen YS
    J Microbiol Immunol Infect; 2016 Oct; 49(5):729-736. PubMed ID: 25442858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discordance Between Tuberculin Skin Test and Interferon-γ Release Assay in Children Younger Than 5 Years Who Have Been Vaccinated With Bacillus Calmette-Guérin.
    Pavić I; Katalinić-Janković V; Čepin-Bogović J; Rešić A; Dodig S
    Lab Med; 2015; 46(3):200-6. PubMed ID: 26199259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tuberculosis Infection in the United States: Prevalence Estimates from the National Health and Nutrition Examination Survey, 2011-2012.
    Miramontes R; Hill AN; Yelk Woodruff RS; Lambert LA; Navin TR; Castro KG; LoBue PA
    PLoS One; 2015; 10(11):e0140881. PubMed ID: 26536035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relating Tuberculosis (TB) Contact Characteristics to QuantiFERON-TB-Gold and Tuberculin Skin Test Results in the Toronto Pediatric TB Clinic.
    Rose W; Read SE; Bitnun A; Rea E; Stephens D; Pongsamart W; Kitai I
    J Pediatric Infect Dis Soc; 2015 Jun; 4(2):96-103. PubMed ID: 26407408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycobacterium Tuberculosis Infection, Immigration Status, and Diagnostic Discordance: A Comparison of Tuberculin Skin Test and QuantiFERON-TB Gold In-Tube Test Among Immigrants to the U.S.
    Wilson FA; Miller TL; Stimpson JP
    Public Health Rep; 2016; 131(2):303-10. PubMed ID: 26957665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.